Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients

被引:44
|
作者
van de Putte, Dietje E. Fransen [1 ]
Fischer, Kathelijn [1 ,2 ]
Pulles, Astrid E. [1 ]
Roosendaal, Goris [1 ]
Biesma, Douwe H. [3 ]
Schutgens, Roger E. G. [1 ]
Mauser-Bunschoten, Eveline P. [1 ]
机构
[1] Univ Med Ctr Utrecht, Van Creveldklin, Dept Hematol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands
关键词
Cardiovascular disease; Co-morbidity; Haemophilia; Malignancy; Myocardial infarction; KNOCKOUT MICE; MORTALITY; DEATH; COHORT; COAGULATION; LIFE; CARE;
D O I
10.1016/j.thromres.2011.12.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: With increasing life expectancy, more haemophilia patients will be confronted with age-related problems. To ensure optimal care, it is important to know the occurrence of both fatal and non-fatal cardiovascular disease, malignancies and other types of co-morbidity in these patients. Our aim was to retrospectively assess the occurrence of co-morbidity and causes of death in a substantial birth-cohort of haemophilia patients. Methods: Data on all types of co-morbidity were collected frommedical records of 408 haemophilia patients (204 severe, 204 non-severe) born before 1971, and compared with the Dutch age-matched general male population. Results: Ten patients had 11 myocardial infarctions, none of which were fatal. The cumulative incidence of non-fatal myocardial infarction was significantly lower in patients with severe haemophilia than in the general population (0.5% versus 4.8%), but was not decreased in patients with non-severe haemophilia (4.4%). Intracranial bleeding occurred significantly more often in haemophilia patients. The occurrence of non-virus related malignancies, and other non-virus related co-morbidities was similar in haemophilia patients and the general population. HIV infection was present in 12% of patients, and hepatitis C infection in 56%. Seventy-eight patients (19%) were deceased. Main causes of death were malignancies, AIDS, hepatitis C, and intracranial bleeding. Conclusions: Our results showed a decreased occurrence of myocardial infarction in patients with severe haemophilia, suggesting a protective effect of very low clotting factor levels on thrombotic cardiac events. No differences were found between haemophilia patients and the general population in the occurrence of any other type of non-virus related co-morbidity. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
  • [41] Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins
    Agrawal, A.
    Lynskey, M. T.
    Bucholz, K. K.
    Martin, N. G.
    Madden, P. A. F.
    Heath, A. C.
    PSYCHOLOGICAL MEDICINE, 2007, 37 (01) : 49 - 60
  • [42] Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly-diagnosed type 2 diabetes mellitus
    Pinies, J. A.
    Gonzalez-Carril, F.
    Irigoien, I.
    Arteagoitia, J. M.
    Altzibar, J. M.
    Rodriguez-Murua, J. L.
    Echevarriarteun, L.
    DIABETOLOGIA, 2014, 57 : S497 - S498
  • [43] Analysis of vascular co-morbidity in patients with atheromatous renovascular disease (RVD).
    Kalra, PA
    MacDowall, P
    ODonoghue, DJ
    Cain, S
    Waldek, S
    Mamtora, H
    Lang, IL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0722 - A0722
  • [44] Use of β-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity -: Safety issues
    Andrus, Miranda R.
    Loyed, Joyce V.
    DRUGS & AGING, 2008, 25 (02) : 131 - 144
  • [45] Oxidative stress and periodontal co-morbidity in patients with chronic kidney disease
    Dias, H. K. I.
    Sharma, P.
    Stringer, S.
    Cockwell, P.
    Chapple, I. L. C.
    Griffiths, H. R.
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 139 : S19 - S20
  • [46] Lipoprotein(a) predicts fatal but not non-fatal cardiovascular events: The Kuopio Ischaemic Heart Disease Risk Factor Study
    Nyyssonen, K
    Laukkanen, J
    Tuomainen, TP
    Salonen, JT
    CIRCULATION, 2002, 106 (19) : 729 - 729
  • [47] Physical Activity and Risk of Fatal or Non-Fatal Cardiovascular Disease Among CVD Survivors - The JMS Cohort Study
    Shibata, Yosuke
    Hayasaka, Shinya
    Yamada, Tomoyo
    Ojima, Toshiyuki
    Ishikawa, Shizukiyo
    Kayaba, Kazunori
    Gotoh, Tadao
    Nakamura, Yosikazu
    CIRCULATION JOURNAL, 2011, 75 (06) : 1368 - 1372
  • [48] NON-EXERCISE ALGORITHMS TO ESTIMATE CARDIORESPIRATORY FITNESS: ASSOCIATIONS WITH MORTALITY AND NON-FATAL CARDIOVASCULAR DISEASE
    Artero, E. G.
    Sui, X.
    Jackson, A. S.
    Blair, S. N.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 899 - 900
  • [49] Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction
    von Kaenel, Roland
    Hari, Roman
    Schmid, Jean Paul
    Wiedemar, Lina
    Guler, Erika
    Barth, Juergen
    Saner, Hugo
    Schnyder, Ulrich
    Begre, Stefan
    JOURNAL OF CARDIOLOGY, 2011, 58 (01) : 61 - 68
  • [50] PREDICTORS OF STATIN UTILIZATION IN US PATIENTS WITH NON-FATAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Williams, A. O.
    Fan, W.
    Armstrong, S.
    Demissie, K.
    VALUE IN HEALTH, 2017, 20 (05) : A264 - A264